Keyphrases
Chronic Hepatitis C
100%
Primary Biliary Cholangitis
75%
COVID-19
64%
Transient Elastography
63%
Liver Stiffness
55%
Fibrosis
51%
Liver Fibrosis
47%
Primary Biliary Cirrhosis
45%
Autoimmune Hepatitis
35%
Ursodeoxycholic Acid
33%
Liver Transplantation
31%
Liver Biopsy
30%
Cirrhosis
29%
Hepatocellular Carcinoma
28%
Systemic Sclerosis
28%
Chronic Liver Disease
24%
Alcoholic Liver Disease
20%
Clinical Course
20%
Liver Transplant Recipients
20%
Liver
19%
Vibration-controlled Transient Elastography
19%
Hepatitis C Virus
17%
Hepatic Iron Content
17%
Cytochrome P450 2E1 (CYP2E1)
17%
Autoantibodies
17%
Growth Arrest-specific Gene 6 (Gas6)
17%
Spleen
17%
Working Diagnosis
16%
Liver Disease
16%
Steatosis
15%
Risk Factors
15%
Upper Normal Limit
15%
Bilirubin
14%
Clinical Significance
14%
Prognostic Model
13%
Hepatitis C Virus Infection
13%
Antibody-associated
13%
Direct-acting Antivirals
13%
Spleen Stiffness Measurement
12%
Liver Involvement
12%
Oxidative Stress
12%
Inflammation
11%
Chronic Autoimmune Diseases
11%
Odds Ratio
11%
Ascites
11%
Genome-wide Meta-analysis
11%
Antiphospholipid Antibodies
11%
Mycophenolate
11%
Etiology
11%
Autoimmunity
11%
Medicine and Dentistry
Primary Biliary Cirrhosis
98%
Transient Elastography
83%
Fibrosis
58%
Liver Fibrosis
48%
Hepatitis C
37%
Liver Transplantation
34%
Chronic Hepatitis C
34%
COVID-19
34%
Liver Biopsy
32%
Autoimmune Hepatitis
28%
Liver Cirrhosis
24%
Chronic Liver Disease
24%
Hepatocellular Carcinoma
23%
Ursodeoxycholic Acid
22%
Systemic Scleroderma
22%
Disease Course
20%
Hepatitis C Virus
20%
Alkaline Phosphatase
18%
Reproducibility
17%
Severe Acute Respiratory Syndrome Coronavirus 2
14%
Antiviral Drug
14%
Bilirubin
13%
Chronic Viral Hepatitis
13%
Cholestasis
13%
Iron
12%
Liver Disease
12%
Decompensated Liver Cirrhosis
12%
Antiviral Therapy
11%
Infection
11%
Diseases
11%
Fatty Liver
11%
Ascites
11%
Growth Disorder
11%
Autoimmunity
11%
Esophageal Varices
11%
Steatosis
10%
Portal Hypertension
10%
Receptor
10%
Biological Marker
10%
Graft Dysfunction
9%
Liver Graft
9%
Alcohol Consumption
8%
Peripheral Edema
8%
FibroScan
8%
Cohort Analysis
8%
Chronic Hepatitis
8%
Diabetes Mellitus
7%
Immunotherapy
7%
Liver Injury
7%
Patient Referral
7%
Pharmacology, Toxicology and Pharmaceutical Science
Primary Biliary Cirrhosis
70%
Diseases
56%
Fibrosis
49%
Chronic Hepatitis C
46%
Liver Fibrosis
41%
Coronavirinae
39%
Hepatitis C
30%
Iron
30%
Liver Cirrhosis
29%
Autoimmune Hepatitis
28%
Systemic Sclerosis
28%
Liver Cell Carcinoma
28%
Ursodeoxycholic Acid
27%
Cohort Study
25%
SARS Coronavirus
24%
Disease Course
21%
Hepatitis C Virus
21%
Antiviral Drug
18%
Alkaline Phosphatase
17%
Growth Disorder
17%
Receptor
16%
Bilirubin
15%
Antivirus Agent
13%
Infection
13%
Chronic Liver Disease
12%
Inflammation
11%
Albumin
10%
Steatosis
10%
Liver Injury
9%
Fatty Liver
9%
Biological Marker
8%
Cholestasis
8%
Immunosuppressive Agent
8%
Diabetes Mellitus
7%
Chronic Hepatitis
7%
Mitochondrion Antibody
7%
Clinical Feature
7%
Liver Disease
6%
Tacrolimus
6%
Immunotherapy
6%
Immune Checkpoint Inhibitor
6%
Malonaldehyde
6%
4 Hydroxynonenal
6%
Alcohol Liver Disease
6%
Virus RNA
6%
Autoimmune Disease
6%
COVID-19 Vaccine
6%
Prevalence
6%
Viral Clearance
5%
Hospital Mortality
5%
